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Abstract
Background: The Liverpool Care Pathway (LCP) is an interdisciplinary protocol, aiming to ensure that dying
patients receive dignified and individualized treatment and care at the end-of-life. LCP was originally developed in
1997 in the United Kingdom from a model of cancer care successfully established in hospices. It has since been
introduced in many countries, including Norway. The method was withdrawn in the UK in 2013. This review
investigates whether LCP has been adapted and validated for use in nursing homes and for dying people with
dementia.
Methods: This systematic review is based on a systematic literature search of MEDLINE, CINAHL, EMBASE, and Web
of Science.
Results: The search identified 12 studies, but none describing an evidence-based adaption of LCP to nursing home
patients and people with dementia. No studies described the LCP implementation procedure, including strategies
for discontinuation of medications, procedures for nutrition and hydration, or the testing of such procedures in
nursing homes. No effect studies addressing the assessment and treatment of pain and symptoms that include
dying nursing home patients and people with dementia are available.
Conclusion: LCP has not been adapted to nursing home patients and people with dementia. Current evidence, i.e.
studies investigating the validity and reliability in clinically relevant settings, is too limited for the LCP procedure to
be recommended for the population at hand. There is a need to develop good practice in palliative medicine,
Advance Care Planning, and disease-specific recommendations for people with dementia.
Keywords: Nursing Home, Liverpool Care Pathway, Dementia, Geriatric, Decision-making, End-of-Life-care,
Reliability, Validity, Responsiveness
Backgrounds
The Liverpool Care Pathway (LCP) is an interdisciplin-
ary procedure developed to make sure that dying pa-
tients face sound ethical decision-making regarding
treatment and care, meeting their individual physical, psy-
chosocial, and existential needs in their last days of life [1].
Cost-effective treatment, prevention of unnecessary
emergency interventions, and hospitalization has been de-
scribed as important secondary goals [2].
The LCP has been designed to establish vital care in-
terventions for patients and their families in the last days
of life and early grieving process [3]. The LCP was devel-
oped in the UK nearly 20 years ago, supported by the
Royal Liverpool University Trust and Marie Curie
Centre Liverpool [1]. The method was intended for use
among cancer patients and presumed an open, timely
communication between the treating physician, nursing
staff, patient and relatives. Appropriate use of LCP re-
quires that the responsible physician makes an accurate
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assessment of their patient as truly dying. In recent
years, the procedure has been adopted in the care of
other patient groups than cancer patients, such as
chronic kidney disease [4] and burn victims [5]. LCP re-
ceived broad support, particularly in the UK and is used
in 17 other countries, including Norway.
In the UK, “The Gold Standards Framework for Care
Homes” (GSFCH) was developed in parallel with the imple-
mentation of LCP. The GSFCH offers educational modules,
which include preparing communication (Advance Care
Planning [ACP]) concerning the appointment of a legal
guardian, making antecedent decisions against cardiopul-
monary resuscitation, and giving information about the
LCP [6]. The initiation and follow-up of ACP communica-
tion between patients, relatives and health professionals, in-
cluding a physician, has been established as a prerequisite
for a dignified death in nursing homes (NH) [7, 8].
In England, in 2009, concerns were raised that the use
of LCP could possibly contribute to the shortening of
some patients’ lives (Delvin K. In: The Daily Telegraph.
2009). It was highlighted that especially old people and
patients with other diagnoses than cancer, were put “on
the pathway” without adequate medical assessment and
without adequate communication to relatives [9, 10].
Concerns were addressed in the media and public de-
bates. The media storm eventually led to the independ-
ent review commissioned by the UK Government “More
Care, Less Pathway”, the Neuberger report [11]. The re-
port concluded that LCP could in some instances be a
suitable procedure, yet, based on unclear implementa-
tion strategies and lack of competence, there was a real
danger of misjudgements with fatal consequences. In
contrast to the UK, an open critical debate never took
place in Norway or other countries in Scandinavia.
Furthermore, this process had no effect on the use in
NHs. Since 2006, LCP has been introduced for use in
NHs and among people with dementia [12, 13], and has
also been implemented in approximately 270 institutions
in Norway. To ensure proper assessment and treatment
of pain and distressing symptoms in the dying old, one
has to investigate the evidence base for the use of LCP
in these settings.
This systematic review aims to investigate the evidence
base for the use of LCP in NHs and among dying people
with dementia. The review includes studies where the
procedure has been developed and adapted for the spe-
cific use in this population. More specifically, we aim to
investigate the following research questions:
1. Have the LCP been validated and tested for use in
dying NH patients and people with dementia?
2. What study designs and methods were employed?
3. Which LCP implementation strategies were used
and how were they described?
4. What were the main outcomes of LCP interventions
in NHs?
Methods
Following the PICO (patient, problem or population,
intervention, comparison, control or comparator, and
outcomes) method [14] (Table 1), we conducted a sys-
tematic literature search in the databases PubMed,
CINAHL, EMBASE, and Web of Science with a search
strategy including MESH terms and free text relevant
for the LCP use in NHs and in people with dementia
and terms related to psychometric testing and method
development (validity, reliability, or responsiveness)
(search strategy available as Additional file 1). The
authors reviewed relevant MESH-terms and free text in
collaboration with a trained medical librarian (RKL).
Our search yielded 333 hits and 176 after excluding du-
plicates (Fig. 1). The review includes methodological,
clinical, intervention, quantitative and qualitative studies
that investigates the implementation (including staff
education), and use of LCP. We also included two stud-
ies using GSFCH and LCP, even though the framework
provides a broader approach, including ACP, over longer
periods of time (i.e., not initiated at the end of life). In
addition, we included two papers aimed to highlight
LCP use in general or acute geriatric wards to perhaps
find indications or recommendations regarding the
assessment and treatment of pain and distressing symp-
toms in dying people with different stages of dementia
or diagnoses of dementia. Since the LCP was developed
in 1997 by Ellershaw et al., and later announced in 2001
[1], our search covered the whole time period between
1997 and august 2016. Based on the exclusion criteria
(listed in Table 1), all authors screened potential manu-
scripts at abstract level (n = 176), and engaged in group
discussions regarding manuscripts read in full text
(n = 59) and borderline exclusion cases (see flow chart
over exclusion process, Fig. 1).
The reference lists of included studies were reviewed,
yielding six more manuscripts. In order to extract and
synthesize the content of the included studies, manu-
scripts were read and discussed in group. We agreed on
the content to be extracted, which were then organized
in a data-extraction table. The table were piloted and
discussed. For each included study, we extracted the fol-
lowing information: full manuscript reference, number
of participants, study design and method, type of inter-
vention and control condition (if applicable), time to
follow-up, study setting, and outcomes. After agreeing
on the format of data extraction, at least two of the co-
authors read through each text independently and then
verified the data-extraction in a discussion. Any unclear
material was raised in group discussions. The authors
agreed upon the grading of evidence according to an
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adapted Oxford Centre for Evidence-based Medicine –
Levels of Evidence (available as Additional file 2) [15].
This system allows authors to grade studies on the basis
of quality factors such as sample homogeneity, follow-
up, definition of comparison group, and use of validated
and relevant tests. The ten different levels of evidence
defined in the system are available as Additional file 2.
The review was designed in order to meet the systematic
review standards of the PRISMA guidelines, and it was
registered at the PROSPERO (registration number
42016045802) database.
Results
Based on our systematic search we found that the LCP
has generated a considerable number of publications
and reports, including reviews and ethical and theoret-
ical discussions. This production is still ongoing, with
the latest contribution by Perkins E et al., [13]; a report
on the end of life care in intensive care units and NHs.
It is noteworthy that few publications are peer-reviewed
original research. In total, we identified 12 studies
investigating LCP use in NH patients and people with
dementia. This also included one method paper which
describes the development of a complex intervention
[16]. The results are organized according to themes
evident in the text and Tables 2, 3 and 4: i) Studies
investigating the use of LCP in NHs and people with de-
mentia, ii) Studies investigating the use of the GSFCH
and LCP in NHs and people with dementia, and iii)
Studies investigating the effect or further development
of LCP in acute or general geriatric ward.
Studies investigating the use of LCP in nursing homes
and people with dementia
In a study from Scotland, Watson et al., [12] conducted
a mixed method study to investigate the barriers of the
implementation of the Liverpool care pathway for the
last days of life in nursing homes. Qualitative and quan-
titative data were collected in eight nursing homes
before, during and after the implementation of the LCP,
following a 5-year action research project (Bridges Initia-
tive) which aimed to enhance the quality of end-of-life
care in NHs. Through analyses of field documentation,
group interviews with trained staff, care assistants, GPs,
and relatives, six barriers of the implementation of LCP
in this type of caring settings were identified. Firstly, the
authors highlighted lack of knowledge regarding pallia-
tive care, drug use and symptom control in the NH as a
key barrier. Further, staff may not be able to recognize
when dying is imminent and thus the necessary prepar-
ation would not be possible. The third barrier was lack
of understanding the dying process, possibly because
NHs has been under-resourced for a long time.
Additional barriers were lack of a multidisciplinary team
with shared decision making, training in communica-
tion, and readiness and ability to change. No patient
outcomes were reported.
A study from The Netherlands (NL), contributed to
three papers by Veerbeek et al., [17, 18], and van der
Heide et al., [19]. The trial used a pre- and post-
intervention design of LCP and included a university and
a general hospital, two NHs, and a home care
organization. The majority of the patients had cancer;
LCP was used for 197 of the 255 dying patients (77%).
Compared to baseline, the intervention had better docu-
mentation of care and lower symptom burden [17]. The
second [18] and third article [19] evaluated the effect of
LCP on communication and level of bereavement, and on
end-of-life decision-making practices, respectively. Com-
pared to baseline, no differences were found in communi-
cation and end-of-life care in NHs. However, in these
publications the implementation and use of the LCP in
participating NHs and people with dementia specifically
are not reported, neither were patient outcomes.
In a study from New Zealand, Clark et al., [20] used a
mixed method study design to describe the experience
of LCP use for dying patients among health professionals
in the setting of three aged residential care facilities. In
this study, a questionnaire, uniquely developed for the
study (10 pages, 55 questions), was sent to 194 em-
ployees 12–18 months after LCP distribution. Nine
nurses, two working on a temporary contract, ten
nursing assistants, three physicians and, two unspecified
workers returned the questionnaire (N = 26, response
rate = 13%). Due to a high missing-rate, the results were
based on a selection of 12 items from the 55-question
Table 1 PICO-model indicating the inclusion and exclusion
criteria of this study
Population NH patients and their relatives.
Intervention Liver Pool Care Pathway
Comparison All studies using standard care group comparison,
before/after comparison, as well as studies without
standard means of comparisons were included.
Outcome All outcomes both qualitative and quantitative were
included.
Exclusion
criteria
Studies only including home-dwelling and hospital
patients
Studies only including specific diagnoses (e.g., heart
failure, cancer)
Studies only using chart based interventions where
patients/relatives are left on their own (e.g., advance
directives without conversations).
Studies that only focused on treatment limits (e.g., DNR,
DNH). Publications such as case studies, chronicles,
guidelines, protocols, unsystematic reviews and legal
documents.
Publications in in other languages than English and
Scandinavian.
Publications without abstracts.
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survey. In addition, focus group interviews with 15
participants and 5 one-on-one telephone calls were
completed. The participants provided positive ratings on
LCP in general. However, LCP implementation strategies
and the questionnaire’s validity and reliability were not
reported; no clinical outcome measures were used in this
study.
In a retrospective Dutch survey including relatives
and healthcare professionals by Lokker et al., [21],
questionnaires were distributed 2 months after a
patient’s death. The study included cases where the
patients died in hospitals (n = 117), NHs (n = 67) or
in their own homes (n = 82). The questionnaire
investigated whether the use of LCP had an effect on
the patient’s understanding of death as imminent.
LCP was introduced halfway through the study period
(11/2003 to 02/2006) and was used in approximately
one-third of the cases. Implementation strategies were
not described. While the study reported that 70% of
the patients had cancer, the prevalence of dementia
was not disclosed. The study concluded that the use
of LCP had no effect on the patient’s understanding
of their situation in the dying process.
The before-after controlled retrospective study by
Brannstrom et al., [22], included 19 residential care
homes with 837 patients in one Swedish municipality.
About half of the study participants had dementia [22].
The LCP implementation strategy consisted of a three-
hour educational session for the staff, and an extended
training of senior nurses, responsible for the staff. This
survey-based study included relatives and nursing staff 1
month after a patient’s death, to evaluate the effect of
LCP on pain, distressing symptoms, and QoL. LCP was
introduced halfway through the study period (06/2009
to 10/2011). Relatives of 71 of 220 patients in the inter-
vention group (LCP) and 64 of 204 in the control group
answered to the questions. The outcome measures were
the Edmonton Symptom Assessment System (ESAS) and
Fig. 1 PRISMA based flowchart of the systematic search and review process
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VOICES. The study found that patients in the interven-
tion group were better treated for nausea and dyspnoea
assessed by ESAS, and dyspnoea assessed by VOICES.
They found no effect on QoL or symptoms such as pain
and anxiety.
Finally, the study by Rajmakers et al., [23] was qualita-
tive, involving LCP-implementation managers (stake-
holders) from 10 Dutch organizations (three hospitals,
four hospices or palliative departments of NHs, and three
home services). The study used telephone interviews and
focus group interviews with the stakeholder (consultants,
network coordinators, and project leaders) to identify
barriers and promoters for the LCP implementation. In
this study, participation of one NH is mentioned but it is
unclear whether NHs staff or stakeholders were included
in the study interview. No patient outcomes were
addressed.
Studies investigating the use of the GSFCH and LCP in
nursing homes and people with dementia
Another larger study from Scotland was carried out to im-
plement and evaluate the implementation of the GSFCH
and LCP in seven nursing homes in one Community
Health partnership. The implementation period lasted for
18 months and was undertaken by an experienced pallia-
tive care nurse. In the first paper, Hockely et al., [24]
described in-depth evaluation of professional practices
and residents` outcomes. During the study period, the use
of LCP rose from 3% to 30% and three of seven NHs used
it regularly. Researchers also found a general increase in
Do Not Attempt Resuscitation (DNAR) orders and ACP,
and reduction of hospital admissions or hospital deaths.
However, the assessment and treatment of pain and
distressing symptoms in the dying old or medication use
are not reported. The GSFCH has a much broader ap-
proach to end-of-life care, unfortunately, the estimated
isolated LCP effect was not reported. The other paper by
Watson et al., [25], reported the implementation process
of the GSFCH and LCP by qualitative interviews. Watson
et al. [12] described the barriers of LCP implementation
and use in NH settings such as, the need for palliative care
knowledge, proper drugs and symptom control, the prep-
aration for imminent death, knowing the dying process,
multidisciplinary teamwork, confidence in communicat-
ing, and readiness to change. Noticeably, the authors point
out that the intervention took time to implement, and that
restricted time to follow-up resulted in interviews being
completed before LCP was fully implemented.
Studies investigating the effect or further development of
LCP in acute or general geriatric ward
To give a broad impression of the LCP-use in people with
dementia, we also searched the literature for the key word
“geriatric*” to include those who are in need for admission
to acute geriatric ward or general geriatric ward. A before
and after LCP implementation study in a palliative care
unit and in a general geriatric ward was described by
Ekestrom et al., [26] and included 44 family members of
deceased patients (21 before and 23 after LCP implemen-
tation). Compared to control, relatives in the intervention
group suggested that physicians’ ability to listen to family
members’ concerns was increased. There were no differ-
ences between the groups in relation to pain and symptom
management. However, small numbers of participants in
the LCP sub-groups and a not-randomized (before-after)
study design make generalization of results challenging.
The second study, by Verhofstede et al., [16] took a
methodological approach, which was described as two
phase study: Phase 0 (preclinical phase) consisted of a
non-systematic review to evaluate factors for successful
LCP implementation in the UK, Italy, and NL. Based on
the results, phase 1 (modelling phase) developed a Care
Guide for the Last Days of Life, supportive documenta-
tion, and an implementation guide addressing the older
acute geriatric hospital population. People with dementia
were not mentioned in this context. This is the only
method paper describing the development of the LCP
systematically. However, the study has not yet included
patients; the focus relies on the hospital setting and ex-
cludes people with dementia.
Results summarized in accordance to the research
questions
In summary, regarding the research question 1, we found
no studies that described LCP’s measurement characteris-
tics pertaining to validity, reliability, and responsiveness.
Moreover, we could not identify studies on the adaption
of the LCP to become appropriate for NHs and among
people with dementia.
Relevant to research question 2, our systematic search
identified two before–after intervention studies [17–19, 26],
two retrospective surveys [21, 22], two qualitative studies
[23–25], two mixed-method studies [12, 20], and one
methodology study [16]. There were no randomized con-
trolled trials (RCT) or prospective studies on LCP use in
NHs or people with dementia. None of these studies had a
blinded design.
With research question 3 we aimed to highlight imple-
mentation strategies to promote and facilitate LCP in
clinical NH settings. Most included papers highlight the
necessity of proper implementation. However, only the
study by Brannstrom et al., investigated the effect of
LCP on pain, symptoms, and QoL in the end of life,
before and after LCP implementation [22]. Yet, this was
a retrospective investigation. Meanwhile, we found no
studies describing strategies for discontinuation of
medications, procedures for nutrition and hydration, or
testing of clinical recommendations in NHs. People with
Husebø et al. BMC Medical Ethics  (2017) 18:48 Page 9 of 13
different stages or types of dementia were not men-
tioned in any publication.
Discussion
This systematic review investigated the use of LCP in NHs
and to what extent it has been adapted from its original use
in cancer patients to the use among multimorbid NH
patients and people with dementia. We also included
papers describing the combined use of GSFCH and LCP,
and the use of LCP in acute geriatric wards and general
geriatric wards.
In general, the evidence for methodological LCP adap-
tions for NHs and people with dementia, and the imple-
mentation strategies and use of LCP in these populations
is weak, almost absent, and existing results are not defini-
tive. We acknowledge that RCTs are difficult to complete
in this population, and believe, that other designs could
also provide important evidence. However, our main
concern is that we did not find studies that document the
development and testing of the instrument by including
elderly multimorbid patients or people with dementia.
This suggests that LCP is not adapted and measures of
validity, reliability or responsiveness are lacking in this set-
ting. Research investigating an instrument’s psychometric
properties is a prerequisite, and should include testing of
various aspects of validity, reliability (intra−/interrater, re-
test etc.) and responsiveness (identifying change after
treatment) [32]. NH patients are fragile, multimorbid, and
dependent, with over 80% affected by dementia [27]. To
estimate imminent dying, and the assessment and treat-
ment of pain and distressing symptoms is challenging in
this population [28–30].
We found 12 publications based on nine clinical studies
of varying research quality. Only the study by Brannstrom
et al. was controlled [22]. Meanwhile, the study had low
internal validity because LCP implementation was com-
pleted halfway through the study period. The study was
not blinded, which can contribute to measurement errors
and Hawthorne effect [31]. Other studies had low re-
sponse rates with potential errors and biases, unclear in-
clusion procedures of people with dementia, or lack of
prevalence for LCP use [20, 21]. Documentation of devel-
opment and testing of a method in a clinically relevant
setting is a prerequisite before it may be implemented as a
clinical standard [32]. Conclusive recommendations based
on aggregated evidence are nearly impossible to make.
Despite the scientific weaknesses there are also some
positive actions worth to be mentioned. The Scottish
study by Hockley and Watson reports qualitative ana-
lyses in order to the use of GSFCH and LCP in seven
NHs [24, 25], although the isolated implementation and
effect of LCP was not reported. The results demonstrate
the necessity of a broader communication process, start-
ing early. Also, the article by Watson et al. [12] deserves
attention because it describes the bottlenecks of LCP
implementation and use in these settings and addresses
potential problems in adopting it in NHs and to persons
with dementia 2006. A more recent article highlights the
further development of the LCP to meet the patients’
needs when they are at the end-of-life admitted to an
acute geriatric ward or general geriatric ward [16, 26].
This contribution outlines a stepwise, review process
and plans to adapt LCP for care for the elderly.
Although this approach does not mention different
stages and types of dementia or the necessity of ACP,
the work demonstrates the complexity of clinical field
that LCP originally was set to resolve.
The present review confirms findings from previously
published review articles [33–38]. An updated version
(09/2010 to 06/2013) [34] of a preceding Cochrane re-
port (1950 to 09/2009) [33] described the effect of LCP
on symptoms relief at the end-of-life when compared
with usual care in hospitals, NHs, and at home. The re-
port concluded that there are no controlled studies of
good quality examining the efficacy of LCP on symptom
intensity as well as their quality of life and dying.
Potential barriers such as unpredictable end-of-life
trajectories in non-cancer patients, and lack of skilled
care providers were also discussed [38]. In general, due
to the insufficient validated outcome measures and use
of control conditions in clinical studies, these reviews
did not draw any conclusions based on existing
literature and even recommended that LCP use should
be avoided for use in NH settings and among people
with dementia, until such studies exist [38].
A good death is significant for dying patients and their
families and the complex should start early in the
patient’s individual disease history (Fig. 2). In a commen-
tary published in The Lancet, Currow and colleagues call
attention to the detail that LCP was used without ad-
equate patient assessment by an experienced clinician
and that the implementation was flawed [39]. The
authors question how UK officials could launch the LCP
without research-based support. Economic interests
were mentioned as an explanation and health economic
reports oppose further financial support for LCP-
implementation [40]. It is further not acceptable to
simply transfer the results from cancer patients to other
patient groups with or without dementia [41, 42].
Among patients with dementia, it is far more difficult to
predict the end-of-life than in cancer patients [43]. The
article, “Less ticking the boxes, more providing support”
by Di Leo et al., [44] highlights health professionals’
concerns related to LCP use, such as problems with
organizing participation in education and training pro-
grams; difficulties in including physicians; identification of
the patient as dying; and interpretation of observations
presented in the LCP tick-off form and documentation.
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Although there is existing evidence-based knowledge
about pain assessment and treatment of people with de-
mentia [45, 46], there is currently only one prospective
study that investigates pain and symptom treatment in
dying NH patients, either with or without dementia [47].
Almost 40% died unexpectedly or were not recognised as
being dying and most symptoms, including pain (46%)
and dyspnea (53%), were still frequent at day of death.
Findings are of clinical importance because typical behav-
iour of pain may resemble behaviours that are common in
dementia diseases [45, 46]. This can lead to incorrect
interpretation and treatment of symptoms. In a NH, the
patient’s primary contact is often a nursing assistant with
varied training in end-of-life care. It is an unfair task to
ask an unqualified health worker to tick-off the Yes or No
box to determine whether a dying person with dementia
has pain, dyspnoea or nausea.
Highlighted by the Neuberger Report, the LCP, when
used in the right hands, can provide a model of good
practice for the last days and hours of life [11]. However,
in the wrong hands, the report concluded that the LCP
has been used as an excuse for poor quality of care.
Summarized by Wrigley A., [48] the concerns are largely
based on misconceptions about or improper implemen-
tation of the LCP and a misunderstanding what the LCP
is designed to do. He also argues that the complete
retraction of LCP, could be compared to retracting
morphine or insulin from the marked, “because its
correct use is beneficial but some people incorrectly use
it”. Meanwhile the premise for using morphine or
insulin is high competence, high quality diagnostics, and
the presence of physicians. With this we argue, that a
precautionary stance is pertinent in this context.
Subsequently, an intense effort was initiated in the UK
to ensure competent treatment in the terminal stage.
The recently published National Clinical Guidelines
(NICE) [49], Care of dying adults in the last days of life,
presents diagnostic and treatment alternatives and
thereby supports other international initiatives [9, 10, 43,
50]. Meanwhile, recommendations highlighted in NICE
are based on mainly randomised clinical studies which
were conducted in hospitals or home care services by in-
clusion of cancer patients. NH patients and people with
dementia are not considered. In Norway, almost 50% of
the dying population dies in a NH; 80% have dementia.
Even though financial gain from using the LCP are
not overtly expressed as a goal, proper and regular
education and training of all staff, would be more
costly and time-consuming than the use of the LCP
alone. After criticism in social media in Norway
(Høeg, Morgenbladet 2015), the title of the LCP and
some segments are rephrased. However, as outlined
by O’Dowd [51], a name change is not good enough.
Meanwhile, staff competence as prerequisite to use
this pathway is entirely unknown.
If LCP is not the optimal intervention in NHs, what
should replace it, and how would this be better? In a
comprehensive white paper on behalf of the European
Association for Palliative Care, by Van der Steen and col-
leagues, a Delphi expert rating evaluated 11 domains and
57 recommendations on palliative care and organized the
following domains as important for end of life care in
people with dementia: 1. Optimal treatment of symptoms
and providing comfort, 2. Person-centred care, communi-
cation and shared decision-making, 3. Family care and in-
volvement, 4. Societal and ethical issues, 5. Avoiding overly
Fig. 2 Levels of care and communication to prepare for later stages of life
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aggressive, burdensome or futile treatment, 6. Education of
the health care team, 7. Psychosocial and spiritual support,
8. Continuity of care, 9. Setting care goals and advance
planning, 10. Applicability of palliative care, 11. Prognosti-
cation and timely recognition of dying. Similar topics were
identified for research priorities. Most of all, this process
demonstrates that end of life care in dementia, is not only
isolated to the last hours of life, it is a long preparing
process involving complex and multimorbid patients lack-
ing ability to provide informed consent, and their families.
These challenges need to be met by building competence
and changing attitudes in NH over time.
Conclusions
Our systematic review demonstrates that the LCP has
not been adapted to the individual needs of dying nurs-
ing home patients and people with dementia. In particu-
lar, the validity, reliability, and responsiveness of the tool
have not been tested in the clinical setting. As such, the
LCP is not an evidence-based procedure and health care
authorities have to judge carefully whether the recom-
mendation of the LCP is justifiable. After changing the
name of the procedure, the LCP is still in use in many
countries, as a low-cost camouflage of the real need for
education and competence in nursing homes.
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